Reply to Beyond binary classification of non-proportional hazards: methodological considerations for interpreting pivotal HCC trials

Ezequiel Mauro; Amit Singal; Josep M. Llovet

doi:10.1016/j.jhep.2026.04.018

Related publications

Article2025

Strategies to address non-proportional hazards between survival curves - Lessons from phase III trials in hepatocellular carcinoma

Ezequiel Mauro, Tiago B. R. Castro, Marcus Zeitlhoefler, Allan Hackshaw, MinJae Lee, Tim Meyer, Amit G. Singal, Josep M. Llovet

Article2025

OS-060-YI Phase III trials in hepatocellular carcinoma: IMbrave 050 and strategies to address non-proportional hazards

Ezequiel Mauro, Tiago B. R. Castro, Marcus Zeitlhoefler, Allan Hackshaw, MinJae Lee, Tim Meyer, Amit Singal, Josep M. Llovet

Journal of Hepatology

Article2018

Methodological Recommendations for Trials of Psychological Interventions

Jenny Guidi, Eva-Lotta Brakemeier, Claudi Bockting, Fiammetta Cosci, Pim Cuijpers, Robin B. Jarrett, Michael Linden, Isaac Marks, Charles Siegfried Peretti, Chiara Rafanelli, Winfried Rief, Silvia Schneider, Ulrich Schnyder, Tom Sensky, Elena Tomba, Carmelo Vázquez, Eduard Vieta, Stephan Zipfel, Jesse H. Wright, Giovanni A. Fava

Article2022

Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification

Carla Montironi, Florian Castet, Philipp K. Haber, Roser Pinyol, Miguel Torres‐Martín, Laura Torrens, Agavni Mesropian, Huan Wang, Marc Puigvehí, Miho Maeda, Wei Qiang Leow, Elizabeth Harrod, Patricia Taik, Jigjidsuren Chinburen, Erdenebileg Taivanbaatar, Chinbold Enkhbold, M. Solé Arqués, Michael Donovan, Swan N. Thung, Jaclyn Neely, Vincenzo Mazzaferro, Jeffrey Anderson, Sasan Roayaie, Myron Schwartz, Augusto Villanueva,

Article2011

When should mood stabilizers be withdrawn due to lack of efficacy? Some methodological considerations

Andréa Murru, Francesc Colom, Alessandra Nivoli, Isabella Pacchiarotti, Marc Valentí, Eduard Vieta